Uni-Bio Science Group Limited — Share Issue/Capital Change 2017

Nov 16, 2017

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [25 x 25] intentionally omitted <==

==> picture [31 x 37] intentionally omitted <==

==> picture [24 x 29] intentionally omitted <==

==> picture [117 x 50] intentionally omitted <==

UNI-BIO SCIENCE GROUP LIMITED 聯康生物科技集團有限公司*

(Incorporated in the Cayman Islands with limited liability) (Stock code: 0690)

GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”).

The board of directors of Uni-Bio Science Group Limited (the “ Company ”) hereby announces that on 16 November 2017, share options (the “ Options ”) in respect of 16,620,000 ordinary shares of the Company (the “ Shares ”) were granted to eligible grantees under the share option scheme adopted by the Company on 28 September 2016. The followings are the details of the Options granted:

Date of grant : 16 November 2017 Number of Options granted : 16,620,000 Exercise price of Options granted : HK$0.1574 per Share Closing price of the Shares on the : HK$0.1570 per Share date of grant The average closing price of the : HK$0.1574 per Share Shares for the five business days immediately preceding the date of grant Validity period of the Options : From 16 November 2017 to 15 November 2027 Vesting period of the Options : (i) 5,538,000 Options are vested immediately on 16 November 2017;

• (ii) 5,538,000 Options will be vested on 16 November 2018; (iii) 5,544,000 Options will be vested on 16 November 2019.

• For identification purpose only

1

All of the Share Options granted above were granted to the Directors of the Company, details of which are as follows:

		Number of the
		Share Options
Name of Grantees	Relationship with the Company	granted
Mr. Kingsley LEUNG	Executive Director	6,000,000
Mr. CHEN Dawei	Executive Director	4,060,000
Ms. LAU Chau In	Non-Executive Director	1,640,000
Mr. ZHAO Zhi Gang	Independent non-executive Director	1,640,000
Mr. CHOW Kai Ming	Independent non-executive Director	1,640,000
Mr. REN Qimin	Independent non-executive Director	1,640,000

The grant of the Share Options to the above Directors has been approved by the Board in accordance with rule 17.04(1) of the Listing Rules.

By Order of the Board of Uni-Bio Science Group Limited Kingsley Leung Chairman

Hong Kong, 16 November 2017

As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. Kingsley Leung (Chairman) and Mr. Chen Dawei (Vice-Chairman); one non-executive Director, namely, Ms. Lau Chau In; and three independent non-executive Directors, namely, Mr. Zhao Zhi Gang, Mr. Chow Kai Ming and Mr. Ren Qimin.

2